Petefészekrák: vizsgálatok itt: Kína
185 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in KínaAdebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer
- Where
- Fuzhou
- Életkor
- 18 év to 70 év
- People
- 37
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT06600841 - 2. fázisTaking peopleHS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
- Where
- Beijing, Changchun, Changsha, Chongqing, Dalian, Fuzhou, Guangzhou, Haikou, Hanzhou, Harbin, Hefei, Jinan, Kunming, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Xi’an, Xinjiang, Zhengzhou
- Életkor
- 18 év and over
- People
- 460
- Run by
- Hansoh BioMedical R&D Company
See details and how to joinNCT06014190 - No phaseTaking peopleThe Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 198
- Run by
- Tongji Hospital
See details and how to joinNCT06556342 - No phaseNot yet taking people in KínaExosome-based OCS Scores for Predicting Ovarian Cancer Recurrence
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 509
- Run by
- Lei Li
See details and how to joinNCT06558019 - 2. fázisNot yet taking people in KínaFluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 30
- Run by
- Fudan University
See details and how to joinNCT06552858 - 3. fázisTaking peopleSHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
- Where
- Beijing, Hangzhou
- Életkor
- 18 év and over
- People
- 440
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06394492 - 2. fázisNot yet taking people in KínaSecondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 94
- Run by
- Fudan University
See details and how to joinNCT06544460 - 2/3. fázisNot yet taking people in KínaPlasmodium Immunotherapy for Advanced Ovarian Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 30
- Run by
- CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.
See details and how to joinNCT05924776 - No phaseNot yet taking people in KínaThe Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
- Where
- Suzhou
- Életkor
- 18 év to 80 év
- People
- 80
- Run by
- Geneplus-Beijing Co. Ltd.
See details and how to joinNCT06283875 - 2/3. fázisTaking peopleTrans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
- Where
- Guanzhou
- Életkor
- 18 év and over
- People
- 200
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT03755739 - 1/2. fázisTaking peopleTriplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 100
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05187338 - 1. fázisTaking peopleCLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 200
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05410717 - 2. fázisTaking peopleEfbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
- Where
- Changsha, Hangzhou, Jinan, Nanjing, Qingdao, Taiyuan
- Életkor
- 18 év to 70 év
- People
- 83
- Run by
- Shandong University
See details and how to joinNCT06251947 - 1/2. fázisTaking peopleSafety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer
- Where
- Hefei
- Életkor
- 18 év to 70 év
- People
- 28
- Run by
- Anhui Provincial Cancer Hospital
See details and how to joinNCT06395844 - 2/3. fázisTaking peopleApplication of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC
- Where
- Wenzhou
- Életkor
- 18 év to 70 év
- People
- 10
- Run by
- Second Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT06341907 - No phaseTaking peopleLiquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC )
- Where
- Guangzhou, Shanghai, Shenyang
- Életkor
- 40 év to 75 év
- People
- 168
- Run by
- Fudan University
See details and how to joinNCT06249308 - 2. fázisTaking peopleAdebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer.
- Where
- Fujian
- Életkor
- 18 év to 70 év
- People
- 37
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT05753826 - 1. fázisTaking peopleA Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
- Where
- Wuhu
- Életkor
- 18 év and over
- People
- 36
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06215950 - No phaseTaking peopleBespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 139
- Run by
- Fudan University
See details and how to joinNCT05446545 - No phaseTaking peopleShanghai Ovarian Cancer and Family Care Project
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 3546
- Run by
- Shanghai First Maternity and Infant Hospital
See details and how to joinNCT06118307 - 2. fázisNot yet taking people in KínaFirst-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 44
- Run by
- Sun Yat-sen University
See details and how to joinNCT06063070 - No phaseTaking peopleA Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 200
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05251883 - 3. fázisTaking peopleTC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors
- Where
- Jinan
- Életkor
- 14 év to 65 év
- People
- 129
- Run by
- Beihua Kong
See details and how to joinNCT02429687 - 3. fázisTaking peopleTC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors
- Where
- Jinan
- Életkor
- 14 év to 65 év
- People
- 132
- Run by
- Beihua Kong
See details and how to joinNCT02429700 - No phaseNot yet taking people in KínaCytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 70 év
- People
- 140
- Run by
- Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT05633199